Evoke Pharma, Inc. (EVOK) Stock Ticker
Market factors today
Unlock the full EVOK picture
About Evoke Pharma, Inc.
Evoke Pharma, Inc. operates as a specialized pharmaceutical entity, primarily focused on inventing and bringing to market therapeutic agents for various digestive system illnesses. The company's lead development candidate is Gimoti, a metoclopramide nasal spray, which has progressed through and completed its Phase 3 clinical trials. This medicine is being developed to mitigate symptoms associated with both acute and recurring diabetic gastroparesis, specifically in female patients. Evoke Pharma distributes its offerings to a broad base of healthcare professionals, encompassing digestive disease specialists, internists, general practitioners, and certain other medical providers. Established in 2007, the company's corporate offices are situated in Solana Beach, California.
EVOK stock facts
| Ticker symbol | EVOK |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market cap | $18.9M |
| CEO | Mark A. Kowieski |
| Employees | 3 |
| Headquarters | Solana Beach, CA, US |
| IPO date | 2013-09-25 |
| Website | www.evokepharma.com |
What you can see for EVOK on Tickr
Live EVOK price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EVOK report.
Rankings
FAQ
What is the ticker symbol for Evoke Pharma, Inc.?
The ticker symbol for Evoke Pharma, Inc. is EVOK, listed on the NASDAQ Capital Market.
What is EVOK?
Evoke Pharma, Inc. operates as a specialized pharmaceutical entity, primarily focused on inventing and bringing to market therapeutic agents for various digestive system illnesses. The company's lead development candidate is Gimoti, a metoclopramide nasal spray, which has progressed through and completed its Phase 3 clinical trials. This medicine is being developed to mitigate symptoms…